Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Glycemic Control and Changes in Skeletal Profile in Patients With Type II Diabetes Undergoing Parathyroidectomy for Primary Hyperparathyroidism

NCT05761743 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT05761743
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05761743 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Glycemic Control and Changes in Skeletal Profile in Patients With Type II Diabetes Undergoing Parathyroidectomy for Primary Hyperparathyroidism
Lead sponsor
The Cleveland Clinic
Phase
Observational
Overall status
Active, not recruiting
Start date
February 27, 2023
Completion date
August 1, 2026
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary hyperparathyroidism, type 2 diabetes